Early results of total gastrectomy patients caused by gastric cancer

Early results of lymph node dissection techniques, patients' files, preoperative blood transfusion status, gender, age, operation time, pancreatic fistula development, duodenal anastomotic leak, need for splenectomy due to splenic injury, duration of postoperative hospital stay of patients who were operated curative total gastrectomy due to gastric adenocarcinoma were investigated on mortality between January 2001 and December 2016 at the General Surgery Department of Cukurova University Faculty of Medicine. 148 of these patients (62.7%) were male and 88 (37.3%) were female. The mean age of the patients was 65,5±11,4. In this study group, non-macroscopic tumor-free interventions were evaluated as curative resection. Differentiation grade and type of tumor were analyzed by histopathological evaluation. Histopathological analysis was based on WHO classification. The differences determined according to the type of D1, D2, D3 dissection, operation time, number of lymph nodes, number of metastatic lymph nodes and duration of hospitalization were statistically significant in the study. D1, D2, D3 lymph node dissection in gastric cancer surgery can be performed safely with surgeons with adequate technical knowledge, with lower mortality and morbidity rates in centers with adequate hospital volume. Problems such as stage shift, enlarged lymph node dissection, and skip metastasis will be reduced to the lowest level, so that the patient's disease progression and treatment planning will be more accurate. Gastrectomy and expanded lymph node dissection are gold standard in the treatment of stomach cancer.